6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole, 95.0%, 1g

1-(2-Methoxyquinolin-3-yl)ethan-1-one, 98%, 250mg

1-(6-Bromo-1H-indol-3-yl)-2,2,2-trifluoroethan-1-one, 97%, 250mg

5-Hydroxypentan-2-one (mixture of monomer and dimer), tech, 5g

2-(3-Bromophenyl)pyridine, 95.0%, 25g

Thalidomide-NH-C6-NH2 (TFA), 250mg

3-Azido-7-hydroxycoumarin, min. 98%, 1 mg, plastic packaging.

(E)-(2-Ethoxyvinyl)boronic acid pinacol ester, 95.0%, 1g

4-Bromophthalazin-1(2H)-one, 95.0%, 10g

5-(Chloromethyl)-3-methylisoxazole, 95.0%, 50mg

3-(4-Cyanophenyl)-3-oxo-propionic acid methylester, 95%, 5g

5-(4-PHENYL-5-(TRIFLUOROMETHYL)THIOPHEN-2-YL)-3-(3-(TRIFLUOROMETHYL)PHENYL)-1,2,4-OXADIAZOLE, 95%, 5mg

Ethyl thiosalicylate, 250mg